Suppr超能文献

早期直肠癌局部治疗的肿瘤学结果。

Oncological outcome after local treatment for early stage rectal cancer.

机构信息

Department of Colorectal Surgery, Churchill Hospital, Oxford University Hospital, NHS Foundation Trust, Old Road, Headington, OX3 7LE, Oxford, UK.

Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.

出版信息

Surg Endosc. 2022 Jan;36(1):489-497. doi: 10.1007/s00464-021-08308-1. Epub 2021 Feb 5.

Abstract

BACKGROUND

Treatment of early rectal cancer is evolving towards organ-preserving therapy which includes endoscopic resection and transanal approaches. We aimed to explore the role of local treatments such as endoscopic polypectomy (Endoscopic Mucosal Resection (EMR) or Endoscopic submucosal dissection (ESD)) and transanal endoscopic microsurgery/ transanal minimal invasive surgery (TEM/TAMIS) in patients who had early rectal cancer. We considered these outcomes alongside conventional major surgery using total mesorectal excision (TME) for early stage disease.

METHODS

All patients identified at MDT with early stage rectal cancer at our institution between 2010 and 2019 were included. Long-term outcomes in terms of local recurrence, survival and procedure-specific morbidity were analysed.

RESULTS

In total, 536 patients with rectal cancer were identified, of which 112 were included based on their pre-operative identification at the MDT on the basis that they had node-negative early rectal cancer. Among these, 30 patients (27%) had the lesion excised by flexible endoscopic polypectomy techniques (EMR/ESD), 67 (60%) underwent TEM/TAMIS and 15 (13%) had major surgery. There were no differences in patient demographics between the three groups except for TEM/TAMIS patients being more likely to be referred from another hospital (p < 0.001) and they were less active (WHO performance status p = 0.04). There were no significant differences in overall survival rates and cancer-specific survival between the three treatment groups. The 5-year overall survival rate for endoscopic polypectomy, TEM/TAMIS or major resection was 96% versus 90% and 88%, respectively (p = 0.89). The 5- year cancer-specific survival rate was 96%, versus 96% and 100%, respectively (p = 0.74).

CONCLUSION

Endoscopic polypectomy by EMR/ESD is an appropriate local treatment for early stage rectal cancer in selected patients. It is possible to achieve good oncological outcomes with a polypectomy similar to TEM/TAMIS and major surgery; however, a multidisciplinary approach is necessary enabling close surveillance and the use of adjuvant radiotherapy.

摘要

背景

早期直肠癌的治疗正在向保留器官的治疗方法发展,包括内镜下切除和经肛门方法。我们旨在探讨局部治疗方法(如内镜息肉切除术(内镜黏膜切除术(EMR)或内镜黏膜下剥离术(ESD))和经肛门内镜微创手术/经肛门微创外科(TEM/TAMIS))在患有早期直肠癌患者中的作用。我们考虑了这些结果,以及使用全直肠系膜切除术(TME)治疗早期疾病的传统主要手术。

方法

我们纳入了 2010 年至 2019 年期间在我们机构的 MDT 中被诊断为早期直肠癌的所有患者。分析了局部复发、生存和特定手术的发病率等长期结果。

结果

共发现 536 例直肠癌患者,其中 112 例患者基于 MDT 术前诊断为淋巴结阴性早期直肠癌。其中,30 例(27%)患者采用灵活内镜息肉切除术技术(EMR/ESD)切除病变,67 例(60%)患者行 TEM/TAMIS,15 例(13%)患者行主要手术。三组患者的人口统计学特征无差异,但 TEM/TAMIS 患者更可能来自其他医院(p<0.001),他们的活动能力较低(WHO 表现状态 p=0.04)。三组治疗方法的总生存率和癌症特异性生存率无显著差异。内镜息肉切除术、TEM/TAMIS 或主要切除术的 5 年总生存率分别为 96%、90%和 88%(p=0.89)。5 年癌症特异性生存率分别为 96%、96%和 100%(p=0.74)。

结论

对于选择合适的患者,EMR/ESD 内镜息肉切除术是早期直肠癌的一种合适的局部治疗方法。通过息肉切除术可以获得类似于 TEM/TAMIS 和主要手术的良好肿瘤学结果;然而,需要多学科方法,以便密切监测并使用辅助放疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8741713/9a55c5cf5a60/464_2021_8308_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验